Dietary arachidonic acid suppresses bone turnover in contrast to low dosage exogenous prostaglandin E2 that elevates bone formation in the piglet

Prostaglandins Leukotrienes and Essential Fatty Acids

Volumn 68, Issue 6, 2003, Pages 407-413

  Lucia, Vienna D ^a   Fitzpatrick Wong, Shirley C ^a   Weiler, Hope A ^a  

^a UNIVERSITY OF MANITOBA   (Canada)

Author keywords

Arachidonic acid; Bone metabolism; Bone mineralization; Prostaglandin E2

Indexed keywords

ARACHIDONIC ACID; OMEGA 3 FATTY ACID; OMEGA 6 FATTY ACID; OSTEOCALCIN; PROSTAGLANDIN E2; SODIUM CHLORIDE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; BONE MASS; BONE METABOLISM; BONE MINERAL; BONE TURNOVER; CALCIUM EXCRETION; CELL ACTIVITY; CONFERENCE PAPER; CONTROLLED STUDY; DIET SUPPLEMENTATION; DIETARY INTAKE; DRUG EFFECT; DRUG MECHANISM; FAT INTAKE; MALE; NONHUMAN; OSSIFICATION; OSTEOBLAST; OSTEOLYSIS; PRIORITY JOURNAL; SWINE;

EID: 0037974175     PISSN: 09523278     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0952-3278(03)00065-6     Document Type: Conference Paper

References (30)

1. B. Watkins, L. Yong, K. Allen, W. Hoffmann, M. Seifert, Dietary ratio of (n-6)/(n-3) polyunsaturated fatty acids alters the fatty acid composition of bone compartments and biomarkers of bone formation in rats, J. Nutr. 130 (2000) 2274-2284.
2. H.A. Weiler, S.C. Fitzpatrick-Wong, Modulation of essential (n-6):(n-3) fatty acid ratios alters fatty acid status but not bone mass in piglets, J. Nutr. 132 (2002) 2667-2672.
3. N. Claassen, H. Potgieter, M. Seppa, et al., Supplemented gamma-linolenic acid and eicsapentaenoic acid influence bone status in young male rats: effects on free urinary collagen crosslinks, total urinary hydroxyproline, and bone calcium content, Bone 16 (1995) 385S-392S.
4. N. Claassen, H. Coetzer, C.M. Steinmann, M.C. Kruger, The effect of different n-6/n-3 essential fatty acid ratios on calcium balance and bone in rats, Prostaglandins Leukot. Essent. Fatty Acids 53 (1995) 13-19.
5. C.K. Schlemmer, H. Coetzer, N. Claassen, M.C. Kruger, Oestrogen and essential fatty acid supplementation corrects bone loss due to ovariectomy in the female Sprague Dawley rat, Prostaglandins Leukot. Essent. Fatty Acids 61 (1999) 381-390.
6. M.C. Kruger, H. Coetzer, R. de Winter, G. Gericke, D.H. van Papendorp, Calcium, gamma-linolenic acid and eicosapentaenoic acid supplementation in senile osteoporosis, Aging (Milano) 10 (1998) 385-394.
7. H. Weiler, Dietary supplementation of arachidonic acid is associated with higher whole body weight and bone mineral density in growing pigs, Pediatr. Res. 47 (2000) 692-697.
8. H.A. Weiler, S. Fitzpatrick-Wong, Dietary long-chain polyunsaturated fatty acids minimize dexamethasone- induced reductions in arachidonic acid status but not bone mineral content in piglets, Pediatr. Res. 51 (2002) 282-289.
9. 2 production, insulin-like growth factor-1 concentration and formation rate in chicks, J. Nutr. 127 (1997) 1084-1091.
10. L.G. Raisz, Prostaglandins and bone: physiology and pathophysiology, Osteoarthritis Cartilage 7 (1999) 419-421.
11. 2 biosynthesis, tissue IGF-1 levels, and bone morphometry in chicks, J. Bone Miner. Res. 11 (1996) 1321-1332.
12. 2 prevents bone loss and adds extra bone to immobilized distal femoral metaphysis in female rats, Bone 13 (1992) 11-22.
13. 2 prevents disuse-induced cortical bone loss, Bone 13 (1992) 153-159.
14. 2 administration prevents bone loss induced by orchidectomy in rats, J Bone Miner. Res. 10 (1995) 66-73.
15. 2 in young rats increases the osteogenic capacity of bone marrow, Bone 20 (1997) 521-526.
16. Canadian Council on Animal Care, Guide to the Care and Use of Experimental Animals, 2nd Edition, Bradda Printing Services Inc., Ottawa, Canada, 1993.
17. National Research Council, Nutrient Requirements of Swine, 10th Edition, Academy Press, Washington, DC, 1998.
18. 2 increases the skeletal response to mechanical loading, J. Bone Miner. Res. 12 (1997) 276-282.
19. J. Folch, M. Lees, G. Stanley, A simple method for total lipid-extraction and purification, J. Biol. Chem. 226 (1957) 497-509.
20. A. Pointillart, I. Denis, C. Colin, H. Lacroix, Vitamin C supplementation does not modify bone mineral content or mineral absorption in growing pigs, J. Nutr. 127 (1997) 1514-1518.
21. A.M. Bollen, KJ. McCulloch, S.W. Herring, Whole body bone resorption in the growing pig, Growth Dev. Aging 61 (1997) 181-189.
22. J.A. Brunton, H.A. Weiler, S.A. Atkinson, Improvement in the accuracy of dual energy x-ray absorptiometry for whole body and regional analysis of body composition: validation using piglets and methodologic considerations in infants, Pediatr. Res. 41 (1997) 590-596.
23. P. Albertazzi, K. Coupland, Polyunsaturated fatty acids. Is there a role in postmenopausal osteoporosis prevention?, Maturitas 42 (2002) 13-22.
24. 3 in three osteoblast-like cell lines (MC-3T3-E1, ROS 17/2.8, and MG-63), Bone 13 (1992) 51-58.
25. J.M.W. Quinn, A. Sabokbar, M. Denne, M.-C. de Vernejoul, J.O.D. McGee, N.A. Athanasou, Inhibitory and stimulatory effects of prostaglandins on osteoclast differentiation, Calcif. Tissue Int. 60 (1997) 63-70.
26. G. Priante, L. Bordin, E. Musacchio, G. Clari, B. Baggio, Fatty acids and cytokine mRNA expression in human osteoblastic cells: a specific effect of arachidonic acid, Clin. Sci. (London) 102 (2002) 403-409.
27. 2, Steroids 64 (1999) 129-136.
28. W.S. Simonet, D.L. Lacey, C.R. Dunstan, et al., Osteoprotegerin: a novel secreted protein involved in the regulation of bone density, Cell 89 (1997) 309-319.
29. H. Brandstrom, T. Bjorkman, O. Ljunggren, Regulation of osteoprotegerin secretion from primary cultures of human bone marrow stromal cells, Biochem. Biophys. Res. Commun. 280 (2001) 831-835.
30. E.A. O'Brien, J.H. Williams, M.J. Marshall, Osteoprotegerin is produced when prostaglandin synthesis is inhibited causing osteoclasts to detach from the surface of mouse parietal bone and attach to the endocranial membrane, Bone 28 (2001) 208-214.